- Ioannis Tarnanas, Ph.D. - Co-Founder and Chief Scientific Officer (CSO)
Active digital biomarkers provide a new understanding of neurocognitive function.
Five-year study on Altoida's simulation of ADL's to predict Alzheimer's conversions.
Dr. Tarnanas presents Altoida at TedX in Zurich; goes on to win EIT Innovators Award 2018.
Four-year study validating Altoida's 94% diagnostic accuracy for AD.
Critical publication shows Altoida is the most sensitive measurement device.
Altoida's Breakthrough designation pioneers Precision Neurology.
Revolutionizing Brain Health
Chief Executive Officer (CEO)
Ioannis Tarnanas, Ph.D.
Co-Founder, Chief Scientific Officer (CSO)
MAXIMILIAN BÜGLER, PH.D.
Chief Technology Officer (CTO)
Vice President of Operations
Senior director of strategic marketing
Senior Director of Project Management
Robbert Harms, Ph.D.
Director of Data Science
director of global marketing
Director, Clinical Research
Senior Software Engineer
Proud to be working with:
Join the Revolution
Discover Your Path to Better Brain Health